ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: On the other hand, our study revealed an interesting peculiarity of the Bajio population, and it was the high proportion of CML patients negative to BCR::ABL1 transcript expression (15%), also called atypical CML (aCML).